Gossypol exerts its cytotoxic effect on HL-60 leukemic cell line via decreasing activity of protein phosphatase 2A and interacting with human telomerase reverse transcriptase activity

Hematology

Volumn 15, Issue 3, 2010, Pages 144-150

  Sahin, Fahri ^a   Avci, Cigir Biray ^a   Gunduz, Cumhur ^a   Sezgin, Canfeza ^a   Simsir, Ilgin Yildirim ^a   Saydam, Guray ^a  

^a EGE UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

Author keywords

Cytotoxicity; Gossypol; HL 60 cell line; Htert; Protein phosphatase

Indexed keywords

CYTOTOXIC AGENT; GOSSYPOL; MESSENGER RNA; OKADAIC ACID; PHOSPHOPROTEIN PHOSPHATASE 2A; TELOMERASE REVERSE TRANSCRIPTASE; PHOSPHOPROTEIN PHOSPHATASE 2; TELOMERASE; TERT PROTEIN, HUMAN;

ARTICLE; CELL MEDIATED CYTOTOXICITY; CELL STRAIN HL 60; CELL VIABILITY; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVE SITE; ENZYME ACTIVITY; HUMAN; HUMAN CELL; IC 50; PRIORITY JOURNAL; PROTEIN EXPRESSION; WESTERN BLOTTING; ANTAGONISTS AND INHIBITORS; APOPTOSIS; CELL SURVIVAL; DRUG EFFECTS; ENZYMOLOGY; GENETICS; HL 60 CELL LINE; LEUKEMIA, PROMYELOCYTIC, ACUTE; METABOLISM; TUMOR CELL LINE;

APOPTOSIS; CELL LINE, TUMOR; CELL SURVIVAL; GOSSYPOL; HL-60 CELLS; HUMANS; LEUKEMIA, PROMYELOCYTIC, ACUTE; OKADAIC ACID; PROTEIN PHOSPHATASE 2; TELOMERASE;

EID: 77953591515     PISSN: 10245332     EISSN: 16078454     Source Type: Journal    
DOI: 10.1179/102453309X12583347113771     Document Type: Article

References (32)

1. Gilbert NE, O'Reilly JE, Chang CJ, Lin YC. Antiproliferative activity of gossypol and gossypolone on human breast cancer cells. Life Sci 1995; 57: 61-67.
2. Coutinho EM. Gossypol: a contraceptive for men. Contraception 2000; 65: 259-263.
3. Tuszynski GP, Cossu G. Differential effect of gossypol on human melanoma, colon carcinoma, and other tissue culture cell lines. Cancer Res 1984; 44: 768-771.
4. Le Blanc M, Russo J, Kudelka AP, Smith JA. An in vitro study of inhibitory activity of gossypol, a cottonseed extract, in human carcinoma cell lines. Pharmacol Res 2002; 46: 551-555.
5. Wu YW, Chik CL, Knazek RA. An in vitro and in vivo study of antitumor effects of gossypol on human SW-13 adrenocortical carcinoma. Cancer Res 1989; 49: 3754-3758.
6. Wang X, Wang J, Wong SC et al. Cytotoxic effect of gossypol on colon carcinoma cells. Life Sci 2000; 67: 2663-2671.
7. Flack MR, Pyle RG, Mullen NM et al. Oral gossypol in the treatment of metastatic adrenal cancer. J Clin Endocrinol Metab 1993; 76: 1019-1024.
8. Stein RC, Joseph AE, Matlin SA, Cunningham DC, Ford HT, Coombes RC. A preliminary clinical study of gossypol in advanced human cancer. Cancer Chemother Pharmacol 1992; 30: 480-482.
9. Thomas M, von Hagen V, Moustafa Y, Montmasson MP, Monet JD. Effects of gossypol on the cell cycle phases in T-47D human breast cancer cells. Anticancer Res 1991; 11: 1469-1476.
10. Becattini B, Kitada S, Leone M et al. Rational design and real time, in-cell detection of the proapoptotic activity of a novel compound targeting Bcl-XL, Chem Biol 2004; 11: 389-395.
11. Moon DO, Kim MO, Lee JD, Kim GY. Gossypol suppresses NFkappaB activity and NF-kappaB-related gene expression in human leukemia U937 cells. Cancer Lett 2008; 264: 192-200.
12. Mohammad RM, Wang S, Banerjee S, Wu X, Chen J, Sarkar FH. Nonpeptidic small-molecule inhibitor of Bcl-2 and Bcl-XL, (2)-gossypol, enhances biological effect of genistein against BxPC-3 human pancreatic cancer cell line. Pancreas 2005; 31: 317-324.
13. Avci CB, Sahin F, Gunduz C et al. Protein phosphatase 2A (PP2A) has a potential role in CAPE-induced apoptosis of CCRF-CEM cells via effecting human telomerase reverse transcriptase activity. Hematology 2007; 12: 519-525.
14. Eichhorn PJ, Creyghton MP, Bernards R. Protein phosphatase 2A regulatory subunits and cancer. Biochim Biophys Acta 2009; 1795: 1-15.
15. Schönthal AH. Role of serine/threonine protein phosphatase 2A in cancer. Cancer Lett 2001; 170: 1-13.
16. Liu WJ, Jiang JF, Xiao D, Ding J. Down-regulation of telomerase activity via protein phosphatase 2A activation in salvicine-induced human leukemia HL-60 cell apoptosis. Biochem Pharmacol 2002; 64: 1677-1687.
17. Uzunoglu S, Uslu R, Tobu M et al. Augmentation of methylprednisolone- induced differentiation of myeloid leukemia cells by serine/threonine protein phosphatase inhibitors. Leuk Res 1999; 3: 5507-5512.
18. Saydam G, Aydin HH, Sahin F et al. Involvement of protein phosphatase 2A in interferon-alpha-2b-induced apoptosis in K562 human chronic myelogenous leukaemia cells. Leuk Res 2003; 27: 709-717.
19. Chang JS, Hsu YL, Kuo PL, Chiang LC, Lin CC. Upregulation of Fas/Fas ligand mediated apoptosis by gossypol in an immortalized human alveolar lung cancer cell line. Clin Exp Pharmacol Physiol 2004; 31: 716-722.
20. Liu S, Kulp SK, Sugimoto Y et al. The (2)-enantiomer of gossypol possess higher anticancer potency than racemic gossypol in human breast cancer. Anticancer Res 2002; 22: 33-38.
21. Xu L, Yang D, Wang S et al. (2)-gossypol enhances response to radiation therapy and results in tumor regression of human prostate caner. Mol Cancer Ther 2005; 4: 197-205.
22. Wang G, Nikolovska-Coleska Z, Yang CY et al. Structure-based design of potent small-molecule inhibitors of anti-apoptotic Bcl-2 proteins. J Med Chem 2006; 49: 6139-6142.
23. Meng Y, Li Y, Li H et al. (2)gossypol and its combination with imatinib induce apoptosis in human chronic myeloid leukemia cells. Leuk Lymphoma 2007; 48: 2204-2212.
24. van Poznak C, Seidman AC, Reidenberg MM et al. Oral gossypol in the treatment of patients with refractory metastatic breast cancer; a phase I/II clinical trial. Breast Cancer Res Treat 2001; 66: 239-248.
25. Politzer WM. Long-term clinical remission of a patient with chronic lymphocytic leukemia using alternative treatment option: cottonseed oil (gossypol). Phytomedicine 2008; 15: 563-565.
26. Baumgrass R, Weiwad M, Erdmann F et al. Reversible inhibition of calcineurin by polyphenolic aldehyde gossypol. J Biol Chem 2001; 276: 47914-47921.
27. Carruthers NJ, Dowd MK, Stemmer PM. Gossypol inhibits calcineurin activity at multiple sites. Eur J Pharmacol 2007; 555: 106-114.
28. Groth RD, Dunbar RL, Mermelstein PG. Calcineurin regulation of neuronal plasticity. Biochem Biophys Res Commun 2003; 311: 1159-1171.
29. Counter CM, Gupta J, Harley CB, Leber B, Bacchetti S. Telomerase activity in normal leukocytes and in hematologic malignancies. Blood 1995; 85: 2315-2320
30. Kim HR, Christensen R, Park NH, Sapp P, Kang MK, Park NH. Elevated expression of hTERT is associated with dysplastic cell transformation during human oral carcinogenesis in situ. Clin Cancer Res 2001; 7: 3079-3086.
31. Nakamura TM, Morin GB, Chapman KB et al. Telomerase catalytic subunit homologs from fission yeast and human. Science 1997; 277: 955-959.
32. Meyerson M. Role of telomerase in normal and cancer cells. J Clin Oncol 2000; 18: 2626-2634.